(NYSE: WAT) Waters's forecast annual revenue growth rate of 5.57% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Waters's revenue in 2025 is $2,958,387,000.On average, 6 Wall Street analysts forecast WAT's revenue for 2025 to be $182,884,580,858, with the lowest WAT revenue forecast at $181,559,835,696, and the highest WAT revenue forecast at $184,150,152,724. On average, 6 Wall Street analysts forecast WAT's revenue for 2026 to be $195,459,381,809, with the lowest WAT revenue forecast at $192,491,448,840, and the highest WAT revenue forecast at $198,948,824,017.
In 2027, WAT is forecast to generate $209,690,678,616 in revenue, with the lowest revenue forecast at $204,060,066,093 and the highest revenue forecast at $215,321,291,138.